CoChat

Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases

Casanova, S., Rosenberg‐Bourgin, M., Farkast, D., Calmettes, C., Feingold, N., Heshmatl, H. M., Cohen, R., Conte‐Devolx, B., Guillausseau, P. J., Houdent, C., Bigorgne, J. C., Boiteau, V., Caron, J., Modigliani, E. · 1993 · Clinical Endocrinology
Cited by 97

The DOI matches its Crossref record.

Abstract

Summary: OBJECTIVE We report clinical, biochemical, morphological and histological data of phaeochromocytoma in 40 French families and in apparently sporadic cases of multiple endocrine neoplasia (MEN) type 2 A (medullary thyroid carcinoma, phaeochromocytoma, with or without hyperparathyroidism). DESIGN This retrospective study was obtained from cases registered by the‘Groupe d'Etudes des Tumeurs a Calcitonine’ from 1968 to 1990. We analysed the cases having sufficiently precise data on phaeochromocytoma with Pigas Software. PATIENTS Characteristics of phaeochromocytoma In 100 patients with MEN 2 A were reviewed. Phaeochromocytoma was bilateral in 51 %. The disease was inherited in 94 patients from 40 families (40 probands, 54 relatives), and was apparently sporadic In six. RESULTS In this series, diagnostic circumstances were highly suggestive of phaeochromocytoma in 39.8% of the cases, whereas in 43.2%, diagnosis was made through systematic investigations of patients, either before (27.3%) or after (13.6%) thyroidectomy, or after discovery of hyperparathyroidism (2.3%). Fifteen per cent of patients were detected by family screening. Sudden death occurred in 8.9%, malignant phaeochromocytoma In 3%, and ectopic tissue in 4% of the cases. Urinary metanephrines appeared to be the most sensitive screening test. The extent of clinical symptoms was not associated with a particular hormonal pattern. Bilateral adrenalectomy was performed in 60% (in one step in 50%, in two steps in 10%). In these patients, bilateral histological lesions were observed in 92.5%. Simultaneous diagnosis for adrenal and thyroid disease was made in 73.4%, but phaeochromocytoma may be diagnosed before (9.6%) or after (17%) medullary thyroid carcinoma, with an interval greater than 2 years in 25 cases. CONCLUSION Owing to variable clinical symptoms of phaeochromocytoma in these 100 cases of MEN 2 A, systemic biological adrenal assay is required. The search for phaeochromocytoma in medullary thyroid carcinoma (and vice versa) has to be systematically performed, even in apparently sporadic cases. Screening for phaeochromocytoma must be repeated for years, owing to the frequency of bilateral adrenal disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1993.tb00350.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 97

Metadata

Authors
Casanova, S., Rosenberg‐Bourgin, M., Farkast, D., Calmettes, C., Feingold, N., Heshmatl, H. M., Cohen, R., Conte‐Devolx, B., Guillausseau, P. J., Houdent, C., Bigorgne, J. C., Boiteau, V., Caron, J., & Modigliani, E.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1993-05
Volume
38
Issue
5
Pages
531-537
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2131891257
Cited by
97
References
0
FWCI
3.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. https://app.cochat.ai/papers/10.1111/j.1365-2265.1993.tb00350.x
The paper
Casanova, S., Rosenberg‐Bourgin, M., Farkast, D., Calmettes, C., Feingold, N., Heshmatl, H. M., Cohen, R., Conte‐Devolx, B., Guillausseau, P. J., Houdent, C., Bigorgne, J. C., Boiteau, V., Caron, J., & Modigliani, E. (1993). Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1993.tb00350.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.